1) Acellular pertussis vaccine
无细胞百日咳疫苗
1.
Acellular pertussis vaccines result in fewer adverse reactions compared with whol.
无细胞百日咳疫苗(acellular Pertussis Vaccine,aP)的出现对预防接种的接受程度及最终的疾病控制起了重大的推动作用。
3) antipertusis vaccine
抗百日咳疫苗
4) Challenge strain for acellular pertussis vaccine
无细胞百日咳攻击菌
6) DTaP vaccine
无细胞百白破疫苗
1.
By descriptively analyzing data from WHO and domestic data,it is found that acellular pertussis,diphtheria and tetanus combined vaccine(DTaP) is safer and similarly effective compared with the old one,and it had been include into the EPI in more than 78 countries,and DTaP vaccine is available in China now.
利用描述性分析方法,对世界卫生组织、我国关于无细胞百白破疫苗研究的资料进行分析,以了解该疫苗的使用情况。
补充资料：白喉-百日咳-破伤风三联疫苗
白喉-百日咳-破伤风三联疫苗
简称"白、百、破三联疫苗"。是在白喉类毒素和破伤风类毒素的混合物内，加入百日咳杆菌死菌悬液制成的生物制品。主要用于儿童自动免疫，预防白喉，破伤风和百日咳。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条